Santé Industrie Pharmaceutique
8.2K views | +12 today
Follow
 
Scooped by Sandra Boyer
onto Santé Industrie Pharmaceutique
Scoop.it!

Novartis n'exclut pas de céder sa santé animale et l'OTC - Les Échos

Novartis n'exclut pas de céder sa santé animale et l'OTC - Les Échos | Santé Industrie Pharmaceutique | Scoop.it
Novartis n'exclut pas de céder sa santé animale et l'OTC Les Échos Novartis pourrait vendre son activité de santé animale et ses médicaments vendus sans prescription (OTC) s'il ne parvient pas à leur donner une dimension mondiale, a déclaré le...
more...
No comment yet.
Your new post is loading...
Your new post is loading...
Rescooped by Sandra Boyer from GIE GERS - La DATA référence & (big)data en santé
Scoop.it!

#Hébergement des #données de #santé : pourquoi passer directement à la #certification ? via  @esante_gouv_fr ASIP  - #esante #hcsmeufr 

#Hébergement des #données de #santé : pourquoi passer directement à la #certification ? via  @esante_gouv_fr ASIP  - #esante #hcsmeufr  | Santé Industrie Pharmaceutique | Scoop.it
Une nouvelle procédure de certification pour l’hébergement de données de santé à caractère personnel sur support numérique va remplacer l’actuelle procédure d’agrément au 1er avril 2018. A ce titre, l’ASIP Santé encourage vivement les candidats hébergeurs à privilégier la procédure de certification.

Via GIE_GERS
more...
GIE_GERS's curator insight, February 17, 4:25 AM

Une nouvelle procédure de certification pour l’hébergement de données de santé à caractère personnel sur support numérique va remplacer l’actuelle procédure d’agrément au 1er avril 2018. A ce titre, l’ASIP Santé encourage vivement les candidats hébergeurs à privilégier la procédure de certification.

Rescooped by Sandra Boyer from Humanitarian & Cultural Causes in Africa
Scoop.it!

Meet the 'backpack midwife' bringing #healthcare for all #Africa #Development 

Meet the 'backpack midwife' bringing #healthcare for all #Africa #Development  | Santé Industrie Pharmaceutique | Scoop.it
For many people in remote regions access to healthcare is limited, so tech is coming to their aid.

Via Igor Espanhol
more...
Igor Espanhol's curator insight, February 12, 6:18 PM

"Margaret works out of the Kiambu Community Life Centre north of Nairobi, where voluntary health workers are the first point of contact for those seeking medical help."

Rescooped by Sandra Boyer from Social Media and Healthcare
Scoop.it!

Patient Engagement Survey: Social Networks to Improve Patient Health

Patient Engagement Survey: Social Networks to Improve Patient Health | Santé Industrie Pharmaceutique | Scoop.it

In our most recent NEJM Catalyst Insights Council Patient Engagement Survey, “Social Networks to Improve Patient Health,” 99% of respondents acknowledge that social networks are potentially useful in health care delivery, especially for chronic disease management (named by 85% of respondents) and promotion of healthy behaviors such as weight loss, physical activity, and healthy eating (78%).

The NEJM Catalyst Insights Council members surveyed — composed of health care executives, clinical leaders, and clinicians — see significant opportunity to improve health by either building or leveraging existing social networks. The seminal research by the medical sociologist Nicholas Christakis shows the strong linkage of behaviors leading to obesity, smoking, and alcohol use within social networks.

Approximately three-fourths of Insights Council member respondents report their organization uses some type of social network as part of their care delivery initiatives, but 90% say these are not yet mature or only slightly mature.”

Facebook and other social media sites illustrate in everyday life the power of social connectedness and the influences individuals have on one another’s behavior. Historically, care delivery has focused exclusively on individual patients. Awareness is growing that social networks in health care, such as PatientsLikeMe and Connected Living, can help people improve health behaviors. Peer networks can provide information and community to patients who otherwise might struggle alone with a new or existing disease.

From the Patient Engagement Insights Report: Social Networks to Incent Better Health. Click To Enlarge.

 

Approximately three-fourths of Insights Council member respondents report their organization uses some type of social network as part of their care delivery platforms, but 90% report that these approaches are not yet mature or only slightly mature. However, more than 60% of respondents believe that when social networks do mature, the impact on patient engagement, quality of care, and provider engagement will be major to moderate — a significant endorsement of the potential of social networks in support of patient health.

Why are clinicians and health care leaders interested in tapping into social networks? The most obvious reason is that health systems have begun to take on financial risk for populations of patients. When health systems assume risk, they are no longer focused solely on treating disease and are incented to consider an array of options for keeping people healthy. Social networks provide the opportunity for innovative care at a relatively low cost (respondents score cost investment lowest among challenges to scaling these tools). Insights Council members single out disease-specific patient support groups and caregiver support groups as the social network approaches with the most potential (chosen by 75% and 66% of respondents, respectively).

Patients, physicians, and nurses — voted the top three parties who should be involved in developing social networks — will have to give careful thought how to make best use of these platforms. They will have to consider which tools they should use, whether to build or buy, how to integrate into workflows, and how to engage providers and patients successfully and sustainably. ”

Face-to-face communication (whether through group sessions or trainings) is named as the most useful mode of communication for social networks (by 69% of respondents). However, it seems inevitable that technology developments and an effort to more meaningfully engage younger patients will push virtual connections, such as social media sites, higher on the list. Social media platforms are a potentially more stable channel for connections with and among patients. For example, people switch cell phone numbers more frequently (largely due to cost issues) than they do Facebook user names.

In verbatim comments, some survey respondents express concern about HIPAA and other privacy regulations in the use of social media sites. It must be acknowledged, though, that for many years patients have been tapping into social networks such as Alcoholics Anonymous, without concerns about privacy being a barrier. What has been missing is the formal involvement and endorsement by health systems. Insights Council respondents also say they are worried patients will receive flawed information about their diagnosis and treatment on social networks. Council members also are looking for reimbursement models that justify the time necessary to develop, implement, and measure the impact of social networks.

Patients, physicians, and nurses — voted the top three parties who should be involved in developing social networks — will have to give careful thought how to make best use of these platforms. They will have to consider which tools they should use, whether to build or buy, how to integrate into workflows, and how to engage providers and patients successfully and sustainably. We are in the initial stages of this work and look forward to supporting maturation of social networks to improve outcomes.

VERBATIM COMMENTS FROM SURVEY RESPONDENTS

Via Plus91
more...
Rescooped by Sandra Boyer from Buzz e-sante
Scoop.it!

Google, Amazon, Facebook, Apple : quels sont leurs projets dans la santé ?

Google, Amazon, Facebook, Apple : quels sont leurs projets dans la santé ? | Santé Industrie Pharmaceutique | Scoop.it

Amazon s’est associé à deux grandes entreprises américaines, Berkshire Hathaway et JPMorgan Chase, pour créer une assurance santé commune à destination de leurs salariés. Ce n’est pas la première incursion d’un GAFA dans le monde de la santé. Récapitulatif de leurs initiatives.

Via Rémy TESTON
more...
Suzana Biseul PRo's curator insight, February 4, 9:20 AM
Share your insight
Senior, Personnes Agées & Silver Economie's curator insight, February 6, 3:07 AM

Les GAFA à l'assaut de l'univers de la santé

Euris's curator insight, February 6, 4:16 AM
Share your insight
Rescooped by Sandra Boyer from The Future of Wellness & Healthcare
Scoop.it!

Transforming Medical Education with Microsoft HoloLens - YouTube


Via Art Jones
more...
Art Jones's curator insight, January 27, 1:51 PM

Holo Lens

 

The future of health education is being fueled by Microsofts Holo Lens technology.

Rescooped by Sandra Boyer from The Future of Wellness & Healthcare
Scoop.it!

In just two hours, Amazon erased $30 billion in market value for healthcare’s biggest companies

In just two hours, Amazon erased $30 billion in market value for healthcare’s biggest companies | Santé Industrie Pharmaceutique | Scoop.it
Amazon has disrupted fashion, books, furniture, food, cloud-based storage services, and much else besides. Now, it's coming for one of the biggest, most complex industries in the US: healthcare. Today (Jan. 30), Amazon, Berkshire Hathaway, and JPMorgan announced a vague but market-moving plan to launch an independent company that will offer healthcare services t

Via Art Jones
more...
Art Jones's curator insight, January 31, 12:13 PM

Amazon is a dominate force in every consumer facing industry. The next industry Amazon's looking to disrupt is Healthcare.

 

Excerpt:

Amazon has disrupted fashion, books, furniture, food, cloud-based storage services, and much else besides. Now, it’s coming for one of the biggest, most complex industries in the US: healthcare.

 

Today (Jan. 30), Amazon, Berkshire Hathaway, and JPMorgan announced a vague but market-moving plan to launch an independent company that will offer healthcare services to the companies’ employees at a lower cost. The venture, which will be managed by executives from the firms, will be run more like a non-profit, than a for-profit entity.

 

The market value of 10 large, listed health insurance and pharmacy stocks 1 dropped by a combined $30 billion in the first two hours of trading. At the time of writing, insurer MetLife was the hardest hit, down nearly 9% for the day.

Suzana Biseul PRo's curator insight, February 1, 4:40 AM
Today (Jan. 30), Amazon, Berkshire Hathaway, and JPMorgan announced a vague but market-moving plan to launch an independent company that will offer healthcare services to the companies’ employees at a lower cost. The venture, which will be managed by executives from the firms, will be run more like a non-profit, than a for-profit entity.
Rescooped by Sandra Boyer from Management de Santé
Scoop.it!

Sanofi lance la cession de ses génériques européens

Sanofi lance la cession de ses génériques européens | Santé Industrie Pharmaceutique | Scoop.it
Le groupe a fixé à mardi la remise des premières offres indicatives pour le rachat de Zentiva, sa divisio

Via RECIPRO RH
more...
No comment yet.
Rescooped by Sandra Boyer from Management de Santé
Scoop.it!

Médecine du futur, les Français se disent prêts

Médecine du futur, les Français se disent prêts | Santé Industrie Pharmaceutique | Scoop.it
Une enquête CSA Research montre que les Français sont prêts à l’irruption des nouvelles technologies dans leur santé.

Via RECIPRO RH
more...
Suzana Biseul PRo's curator insight, January 15, 5:32 AM
Big data, médecine connectée, robotique ou encore intelligence artificielle... autant d'innovations dont les Français reconnaissent l'importance pour la communauté des chercheurs.
Rescooped by Sandra Boyer from GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK
Scoop.it!

Healthcare Comes Home at CES 2018 #digitalhealthCES #CS2018 #hcsmeufr 

Healthcare Comes Home at CES 2018 #digitalhealthCES #CS2018 #hcsmeufr  | Santé Industrie Pharmaceutique | Scoop.it
Health is the new black if this year’s annual CES 2018 is an indicator. Even the new connected cars have a health story to tell at this yearly get-together of shiny new-new things in consumer-facing technology.Over 100,000 technophiles from around the globe are expected to attend this meet-up, whose exhibition spaces are located throughout Las Vegas. No longer can all these digital things that consumers have come to love, or at least depend on, be housed in the city’s Convention Center. This year, the shiny objects are located in at least five spaces around town.
Via Alex Butler, Lionel Reichardt / le Pharmageek
more...
No comment yet.
Rescooped by Sandra Boyer from GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK
Scoop.it!

#CES2018 : le nouveau salon de la transfo digitale? #30minutesmax #digitalhealthCES #hcsmeufr #esante

#CES2018 : le nouveau salon de la transfo digitale? #30minutesmax #digitalhealthCES #hcsmeufr #esante | Santé Industrie Pharmaceutique | Scoop.it

Nouvel article #30minutesmax sur mes impressions sur le CES2018 avec de la esanté mais aussi d'autres choses. Si vous aimez, partagez !


Via Lionel Reichardt / le Pharmageek
more...
Lionel Reichardt / le Pharmageek's curator insight, January 11, 1:59 PM

Nouvel article #30minutesmax sur mes impressions sur le CES2018 avec de la esanté mais aussi d'autres choses. Si vous aimez, partagez !

Rescooped by Sandra Boyer from Buzz e-sante
Scoop.it!

Les 10 questions de santé les plus posées à Google en 2017

Les 10 questions de santé les plus posées à Google en 2017 | Santé Industrie Pharmaceutique | Scoop.it
Le porte-parole du moteur de recherche américain a dévoilé les dix questions de santé les plus posées à Google en 2017.

Via Rémy TESTON
more...
No comment yet.
Rescooped by Sandra Boyer from Social Media and Healthcare
Scoop.it!

Digital Marketing in Pharma Industry: A Complete Guide

Digital Marketing in Pharma Industry: A Complete Guide | Santé Industrie Pharmaceutique | Scoop.it

Prior to booking an appointment:

 

77% of patients used search83% used hospital websites54% used health insurance company sites50% used health information sites26% used consumer-generated reviews

( Source: Google’s Report on The Digital Journey to Wellness: Hospital Selection )

Digital Marketing should now be part of your overall marketing strategy, no matter which industry you are in. As you might have guessed from above, it is true for Pharma Industry as well. Digital marketing in pharma industry has already picked up and starting to transform the Pharma and Healthcare industry in the ways it has already transformed retail, media, banking, airline, telecom and education industries.

Digital Patient Journey

Pharma companies and its executives have realized the potential and the disruption it can bring-in the pharma sector and have already started making use of and experimenting with the wide range of armaments available in Digital Marketing.

Trends that make Digital Marketing Imperative for Pharma Companies

Today’s generation turns to internet and social media for almost everything in their lives, health topics would be no surprise. However, there are certain trends which are acting as driving force to make Digital Marketing for Pharma companies a must-have.

Let’s look at such key trends:

 

Patients are becoming more aware, more engaged and have more expectations

Historically, the patients have had a much passive role when it comes to their own health treatments. They would simply go and meet the doctor and rely on the medicines prescribed by her and start the treatment. This is because they have very little to no information about the treatment options, drugs on the market and the experience of other patients.

With digitization, before meeting a doctor, the patient researches everything about the disease – its symptoms, diagnosis, possible cures etc and has already interacted with other patients. Patients are also more and more aware of their rights and have high expectations from the service providers and the product companies alike.

 

More information is available about product performance and even the process

Traditionally, pharma companies controlled all the information regarding their products – and they would also control release of this information. They usually used to release this information on need basis (e.g. required by regulators).

The digitization has weakened the control that pharma companies had on information. There is abundance of information available online – people search online for solutions to all of their daily problems. Health problems are no exceptions. Patients share their experiences with drugs, doctors and companies online, which are available for other patients to see. Therefore, in this digital age, patients are increasingly less dependant on their doctors for advices. Instead they rely on plethora of information available online, on mobile apps and they use monitoring devices (e.g. fitbit) and monitoring apps too.

“Two-thirds of people believe they could be making more decisions about personal health and wellness on their own.”

– A survey conducted by Ipsos in collaboration with the National Council on Patient Information and Education and Pfizer, 2015, multivu.com.

Role of Digital Age in Pharma and Healthcare Sector

This number would only have gone up since 2015. Patients are increasingly turning to internet and social media not for supplemental information to add to what they got from doctors and pharma companies but as first source of information.

 

Process efficiency is improving exponentially

Process efficiency is going up across industries with data analytics and automation of complex decisions, in turn improving agility, responsiveness, accuracy and quality of business processes. Pharma industry is no exception, they would also need to apply next-generation technologies to stay in the game.

 

Tailored personalized care

With increased expectations from the whole eco-system, users not only want but rightfully expect personalized care. They are able to get personalized solutions – be it grocery shopping, electronics shopping, spa – salons, banking services, online trading services, telecom services, airline companies and a lot more.

Users expect the same from pharma companies as well. “Patient First” has become the war cry for pharma and healthcare companies, in line with Customer First for other traditional sectors.

Pharma companies can provide personalized care through the right usage of digital services, sensors, tech-enabled devices and through processing the data collected by these. This makes a really strong case for digital marketing in pharma industry.

 


 

 

Multi-channel engagement between patients and doctors

The patients are already starting to use online portals to access their medical records and to interact with their doctors. Patients are starting to use apps to fill forms online and engage with other patients in the online communities.

All of this opens up a whole new set of mediums for pharma and healthcare companies to interact with patients and other users. Using these mediums, the pharma and healthcare companies, through their sales representatives, patient-services teams and other teams, can monitor and influence patients, doctors and other healthcare professionals online through apps, social media, mobile phone messages/notifications and even in person.

Going forward, 24/7 anytime anywhere virtual healthcare is going to become a norm. Leading indicators of such norms can be seen by the developments in the early adopters of technologies.

The US Department of Defense is testing robots to engage and screen soldiers for post-traumatic stress disorder (PTSD) –

“The military is building brain chips to treat PTSD,” Defense One, May 28, 2014, defenseone.com.

United kingdom has ambitious plans to halve the number of outpatient appointments with use of skype consultations. Follow-up advice and prescription would be sent by email.

We believe that these futuristic steps may face some teething problems, but these are definitely the way of times to come.

Image: Digital Marketing in Pharma and Healthcare Sector

 

Don’t just provide drugs, provide full service and better sales practices

A pharma or a healthcare company, like any other profit making business, would want their customers to come back to them whenever they need these services. The companies have to go the extra mile and provide full service support – before (decision making process), during and after sale of product/ service. The idea is to engage the customer during the full process and keep her engaged afterwards, like a personalized healthcare solution provider. Digital marketing is poised to play key role in this arena for the pharma and healthcare sector.

 

Timely and accurate feedback for R&D

Use of digital technologies provides real-time feedback from the whole value-chain including the end-consumer to pharma and healthcare companies. It cannot be stressed enough, how important is that to their research & development centers. In effect, what I am saying is, digital marketing is going to help pharma companies in their R&D, and in turn will lead to better products and solutions for all of us. Also, it is likely to make the R&D expenditure for the pharma companies much more efficient.

And the seamless information flow will help the supply chain management better as well (remember the beer game?). The pharma companies can better predict demand and supply, security of their drugs and vendor/partner performance.

 

Better management of Risk and Compliance functions: Monitor risks and better allocation of resources to manage the same in real-time

The real time feedback from the whole supply chain and end-users, provides the pharma and healthcare companies the capabilities to monitor risks in real time. This in turn enables them to respond in real time by optimizing resource allocation to different activities.

 

Tech-enabled Competitors are Marching in

There was a time when information and insights into clinical pathways and patient’s histories were available only in the traditional healthcare establishment – in the paper records of healthcare providers. These used to remain in the clutches of pharma companies.

Today, the big technology giants such as IBM, Apple and many new startups are making in-roads into the healthcare segment. These new players engage with the patient through digital mediums – apps, fitness and health devices, online forums, video channels, live sessions etc.

Tech Wearables’ Onslaught

They continuously collect data from their users, such as health records, drug purchases, health insurance premiums and claims etc. Then they use advanced data analytics to deliver personalized and precise medical assistance.

Pharma companies will have to tackle the competition arising from these new players. They will either have to create these capabilities themselves or collaborate with some of the new players, or think out-of-box to maintain the leadership position.

Thus, both the customers and the healthcare value chain partners as a whole are moving towards digital – finding solutions/ options online, engaging with other patients/ doctors online. The traditional medical seminars, conferences, magazines and meet-up are evolving too with changing times.

Digital marketing is going to provide the edge required to stay ahead in the race, for pharma and healthcare companies.


Via Plus91
more...
No comment yet.
Rescooped by Sandra Boyer from Digital Delights - Digital Tribes
Scoop.it!

Artificial Intelligence: A Free Online Course from MIT

Artificial Intelligence: A Free Online Course from MIT | Santé Industrie Pharmaceutique | Scoop.it

Today we're adding MIT's course on Artificial Intelligence to our ever-growing collection, .

Via Ana Cristina Pratas
more...
Nik Peachey's curator insight, December 21, 2017 1:56 AM

Given the way things are going, this might well be worth checking out.

Stephen Dale's curator insight, December 22, 2017 5:15 AM
Share your insight
Rescooped by Sandra Boyer from L'Infirmière magazine
Scoop.it!

Vaccination : des YouTubeurs appelés au renfort | Espace-Infirmier

Vaccination : des YouTubeurs appelés au renfort | Espace-Infirmier | Santé Industrie Pharmaceutique | Scoop.it
En marge de l’entrée en vigueur de l’extension de l’obligation vaccinale le 1er janvier 2018, Julien Ménielle, ex-infirmier devenu YouTubeur, a produit une vidéo en partenariat avec le ministère des Solidarités et de la Santé. Objectif : déconstruire les « fausses infos » qui circulent sur les vaccins.

Via L'Infirmière magazine
more...
L'Infirmière magazine's curator insight, January 18, 9:15 AM

Julien Ménielle décortique les "9 bullshits sur les vaccins"

Rescooped by Sandra Boyer from PATIENT EMPOWERMENT & E-PATIENT
Scoop.it!

PHARMA.....CONNAIS TU LES E-PATIENTS?

PHARMA.....CONNAIS TU LES E-PATIENTS? | Santé Industrie Pharmaceutique | Scoop.it

Mi septembre, la nouvelle tombe. "le Mycophénolate Mofétil (Cellcept) est exclu du dispositif "tiers payant contre générique"".
Résultat du travail de "Renaloo", association de patients qui a su mobiliser son réseau et négocier avec l'ANSM et la CNAMTS...
C'est une première....mais ce genre de situation va probablement devenir de plus en plus courante.


A l'occasion de la WebTV que j'ai eu l'honneur d'animer sur BEPATIENT.fr : "Carte blanche" donnée aux "E Patientes" ( http://sco.lt/8VRpi5 ;), j'ai pris le temps de compiler un certain nombre d'informations sur ce qu'on appelle les "E Patients" et ce mouvement connu désormais dans la santé comme le "Patient Empowerment".


On sait que la santé est un sujet très présent sur le web.


Avec plus de 30% de la population mondiale connectée (plus de 71% dans les pays développés), le web 2.0 compte maintenant plus de 100 000 000 de sites et plus d'un milliard d'utilisateurs .


La santé 2.0 en chiffres c'est plus parlant. Cela représente :


- 1/3 des recherches faites sur Google
- 20% des discussion dans les réseaux sociaux


Ce qui fait de la santé le second sujet le plus recherché/discuté sur le net.


E PATIENT : UN PHENOMENE AMERICAIN?


On peut penser que ce mouvement des E Patients est un phénomène anglo-saxon pour ne pas dire américain.


Le plus connu d'entre eux, E Patient DAVE (Dave de Bronkart), sexagénaire américain, est devenu le "fer de lance" de ce mouvement.
Diagnostiqué avec un cancer du rein en 2006, les médecins le laissent sans espoir de traitement. Alors Dave s'adresse au web, échange avec d'autres patients et apprend qu'il y a un traitement envisageable mais proposé uniquement par certains médecins.
Rentré en rémission, il décide de s'appuyer sur son expérience pour promouvoir une approche nouvelle de la santé. (une interview intéressante de E Patient Dave http://www.myfoxmaine.com/story/19595242/e-patient-dave-health-activist)


Le Patient EMPOWERMENT est né avec les différente définitions que l'on peut donner aux E Patients (bien résumé et étayé sur wikipedia http://bit.ly/GShDVf ).


Parmi d'autres celle qui fait l'unanimité est la définition élaborée par Tom Ferguson qui identifie les e-patients comme des individus équipés, capables, responsables et impliqués (equipped, enabled, empowered, engaged) dans leur état de santé et dans les décisions qui lui afférent.


L'étude américaine de PEW INTERNET (Social life of health information ( http://bit.ly/SxW4PK ) résume bien l'ampleur de ce phénomène aux Etats Unis.


80% des internautes ont cherché des informations santé sur le web1/3 s'en sert pour évaluer et choisir leur médecin60% reconnaissent que cela a affecté leur décision sur comment traiter leur pathologie50% demandent alors un second avis médical après ces recherches30% s'en servent pour décider d'aller consulter ou pas30% l'utilisent pour comparer les options de prescription de traitement


Aux Etats Unis ou les professionnels de santé sont équipés à 80% de smartphones et à 60% d'IPAD, 40% d'entre eux reconnaissent aller consulter de l'information on-line PENDANT la consultation et 50% recommandent à leurs patients des sites à consulter (Manhattan Research)


Le mouvement est encore plus évident à la lecture de l'étude conduite par l'université californienne DAVIS (UC DAVIS Mai 2012 http://bit.ly/SxW4PS ) "The prepared patient" qui met en avant les attentes des E Patients :


se tenir informéjouer un rôle actif dans ses soinsfranchir une étape difficile sur une question de santé


Cela pour autant qu'il soit question de défiance vis à vis des professionnels de santé
Par ailleurs, les patients reconnaissent qu'internet n'est pas la seule source d'information ; les amis, les émissions de télé, les ouvrages/revues/magazines.. sont aussi cités. D'ou l'importance de garder une présence sur les médias "off-line".


Dans cette étude, enfin, il est précisé que :


70% des patients discutent avec leurs médecins de l'information collectée.40% l'impriment afin d'en parler avec leur médecin50% déclarent suite à cette recherche avoir au moins une question à poser à leur médecin.


ET EN EUROPE ?


En Europe, les études et la prise de conscience se développent.


Dans son étude "Citizen Health Europe", Manhattan Research dresse en 2010 un état des lieux précis de la situation.


Premier constat, il y aurait 76 millions de E Patients en Europe !!


Parmi les motivations qui induisent à s'adresser au web les 3000 patients interrogés dans les 5 plus gros pays européens, on retrouve :


discuter/rechercher les informations obtenues lors de la consultationutiliser internet pour rechercher des symptômes/diagnostic (le fameux phénomène "Dr Google")challenger le diagnosticdemander un changement de traitement


L'étude conduite en 2010 par IMR international "Europe Social Media in healthcare" quant à elle précise les motivations des internautes pour discuter de la santé sur les réseaux sociaux.


32% veulent trouver une expérience sur le traitement qu'ils prennent31% pour trouver de l'expérience sur la maladie qu'ils ont16% pour partager de l'expérience/maladie13% pour partager de l'expérience/traitement


EN FRANCE ?


C'est ainsi qu'en France l'étude IPSOS "Public affair 2010" nous révèle que que la santé est la 7ème raison de consulter le web (en France).


Et lorsque l'on regarde les sites consultés/moyens utilisés (Etude GFK 2010 http://bit.ly/PxRc0c ) :


81% passent par les moteurs de recherche68% par des sites spécialisés type "Doctissimo" ou "AZ Santé"40% vont sur les forums de discussion38% sur les encyclopédies libres (Wikipédia, ..)


Par contre :


seuls 12% vont sur les sites de labo11% sur des blogs médecins10% sur des blogs de patients10% sur les sites d'associations de patients8% sur les réseaux sociaux


Quant on sait qu'un site comme Doctissimo génère environ 8 à 10 millions de visiteurs uniques par mois, le Ministère de la santé a décidé face à ce phénomène de conduire une étude avec des sociologues en 2010.


La conclusion est sans appel sur le sujet :


Les auteurs précisent qu'il s'agit là de la "CONSTRUCTION D'UN SAVOIR PROFANE PRATIQUE, COMPLEMENTAIRE DU SAVOIR EXPERT DES MEDECINS".


Le phénomène est tel que le CNOM (Conseil National de l'Ordre des médecins) a réagit en conduisant cette enquête avec IPSOS ( http://bit.ly/PjIRtd ) qui nous donne les chiffres pour la France :


71% des internautes français recherchent des informations santé sur le web7 internautes sur 10 qui font ces recherches ne font pas la différence entre sites certifiés ou non62% des français consulteraient le site/blog de leur médecins si celui-ci en avait un34% des internautes qui cherchent sur le net disent en parler avec leur médecin (le deux tiers des patients ne discutent pas avec leur médecins des informations repérées en ligne)


Cela a d'ailleurs conduit le CNOM a inciter sur son site les médecins à se pencher sur ce phénomène pour :


Développer le conseil du médecin dans la recherche d’information santé.Faire d’Internet un outil au service de la relation médecins-patientsCréer un label ordinal pour les sites publiés par des médecins.


ET ALORS ?


And so what??
Comment prendre en compte cette évolution parmi les acteurs du système de santé?

Et oui.. pas facile quand notre culture et notre cadre réglementaire ne nous permettent pas d'avoir un échange directe avec les patients.
Pas facile de passer d'une cible de 200 000 médecins (grosso modo) à près de 45 millions d'individus (juste pour la France)
Pas facile de passer d'un mix promo ou la visite médicale est omniprésente (près de 60% du budget) et le digital quasi absent (moins de 1%)


C'est le "business model" en entier qu'il faut repenser et les organisations qui vont avec....


L'orientation client ne doit plus être une intention... mais devenir une réalité du quotidien...avec la difficulté, certes majeure, de définir ce CLIENT.


Prescripteurs? Dispensateurs? Payeur? Patient?...Lequel choisir? Y en a t il qu'un? ou plusieurs? quel poids donner à chacun?


J'entends souvent, et à juste titre, dire par les acteurs (laboratoires, grossistes, pharmaciens,..) que le Patient est "AU COEUR DE NOS DÉMARCHES"...


Pour les marketeurs (futurs "chef de clients"?? :-)), cela doit se traduire par une cartographie du parcours client...peut être effectivement tournée autour de ce parcours.

Prenons le pari qu'à chaque étape du parcours patient (prévention, symptôme diagnostique annonce,analyses, prescription, dispensation, observance, suivi...que sais je?? selon les pathologies) nous repensons nos démarches marketing en mettent au coeur le patient et la notion de service client et de valeur ajoutée...


Et pourquoi ne pas considérer désormais nos clients historiques ou les nouveaux acteurs comme des partenaires ayant eux aussi pour client le Patient?


Peut être faudrait il dans un premier temps accompagner ce changement dans la relation médecin/patient?


Pour conclure je reprendrais un post récent d'Alex Butler, PDG de "The social Moon", gourou du digital pharma et ancien de J&J, qui s'interrogeait sur la pertinence de continuer à utiliser le terme de E-Patient.
En effet, à partir du moment ou tous les patients ou presque, vont sur le net peut être faut il juste les appeler PATIENTS...au même titre qu'on ne précise plus le terme 'numérique" quant on parle d'appareil photo...


Ça y est Pharma... tu en sais un peu plus sur les E Patients.
J'espère que cela t'aura intéressé.



Pour finir, je citerais Len Starnes, autre gourou du digital pharma et ex Bayer...qui écrivait dans une présentation destinée à la pharma:

"Fish where the fishes are"
(Peches là ou sont les poissons)


A bon entendeur

Lionel REICHARDT
Le Pharmageek


Via Lionel Reichardt / le Pharmageek
more...
Anne Sophie Llanas's curator insight, March 2, 2016 6:40 PM
Qui sont les e patients ? 
Anthony's comment, March 18, 2016 10:07 AM
Merci pour cette analyse !
Anthony's comment, March 18, 2016 10:07 AM
Merci pour cette analyse !
Rescooped by Sandra Boyer from PATIENT EMPOWERMENT & E-PATIENT
Scoop.it!

Combattre les cellules cancéreuses à l'aide de la chimiothérapie #MoiPatient #SpecialCancer #Journeemondialecontrelecancer #WorldCancerDay #WeCanICan #Cancer #hcsmeufr

Combattre les cellules cancéreuses à l'aide de la chimiothérapie #MoiPatient #SpecialCancer #Journeemondialecontrelecancer #WorldCancerDay #WeCanICan #Cancer #hcsmeufr | Santé Industrie Pharmaceutique | Scoop.it
Mode d’action de la chimiothérapie, les différents types de traitement existants et leur mode d'administration   Lorsqu'on demande aux gens de citer les types de traitements existants pour lutter contre le cancer, la chimiothérapie arrive en tête des propositions1. De fait, il s'agit d'un des trois traitements fondamentaux contre le cancer, et aussi le plus…

Via Lionel Reichardt / le Pharmageek
more...
Lionel Reichardt / le Pharmageek's curator insight, February 4, 10:43 AM

Un #MoiPatient Spécial Cancer à l'occasion de la Journée Mondiale de lutte contre le Cancer avec le soutien institutionnel d'Accuray. Première rencontre avec un représentant d'une association de patients dans le domaine avec Natacha Espié, présidente d'EUROPA DONNA FRANCE.

#Journeemondialecontrelecancer #WorldCancerDay #WeCanICan #Cancer #hcsmeufr

Rescooped by Sandra Boyer from Buzz e-sante
Scoop.it!

L’AP-HP lance le Digital Medical Hub

L’AP-HP lance le Digital Medical Hub | Santé Industrie Pharmaceutique | Scoop.it
L’AP-HP, crée à l’hôpital Bichat – Claude-Bernard, la première plateforme d’évaluation et d’analyse des objets connectés en santé, le Digital Medical Hub.

Via Rémy TESTON
more...
No comment yet.
Rescooped by Sandra Boyer from The Future of Wellness & Healthcare
Scoop.it!

Google is training computers to predict when you might get sick

Google is training computers to predict when you might get sick | Santé Industrie Pharmaceutique | Scoop.it
Researchers at Google Brain has analyzed millions of anonymized medical records to try and help predict when people will get sick.

Via Art Jones
more...
Art Jones's curator insight, January 26, 12:37 PM

The Computer as Intelligent Wellness & Health Assistant

 

Google is working on technology to predict what illness you will come down with and when it will happen. Big data, artificial intelligence and machine learning will deliver crystal ball like early diagnosis of illnesses.

Rescooped by Sandra Boyer from Social Media and Healthcare
Scoop.it!

Pharma Social Media Ranking - Global Twitter Edition 2018 -

This 2018 pharma social media ranking from healthcare agency Owen Health provides a snapshot of the performance of 22 of the largest pharma companies on Twitte…

Via Plus91
more...
No comment yet.
Rescooped by Sandra Boyer from Management de Santé
Scoop.it!

La santé connectée, solution pour accorder plus de temps aux patients ?

La santé connectée, solution pour accorder plus de temps aux patients ? | Santé Industrie Pharmaceutique | Scoop.it
Les Français sont globalement très satisfaits de la qualité du travail des soignants mais l'enquête de l'institut de sondage Odoxa publiée ce lundi montre un besoin global, tant pour les patients que pour les médecins, de disposer de plus de temps pour soigner et informer.

Via RECIPRO RH
more...
Suzana Biseul PRo's curator insight, January 22, 5:45 AM
Les répondants, qui ont tous fréquenté un établissement de santé au cours des trois dernières années, reconnaissent la compétence des soignants en large majorité. Mais en revanche, les Français du sondage aimeraient bien qu'on les écoute davantage.
Rescooped by Sandra Boyer from Social Media and Healthcare
Scoop.it!

:Social Media: Taking the Plunge: Pharma and Social Media 

:Social Media: Taking the Plunge: Pharma and Social Media  | Santé Industrie Pharmaceutique | Scoop.it

Pharmaceutical companies are increasingly embracing social media as a forum for reaching patients. For example, 40% of adults use social media for health-related issues, such as connecting with patients with similar issues. Social forums allow pharmaceutical companies to not only engage with consumers or patients, but also hear what they have to say directly, rather than sifting through external forums to find out what patients are saying, for example, about side effects.

Disease awareness is a particularly popular use of social media for pharma companies. These forums are recognized by companies as good ways to improve knowledge about diseases and to encourage discussion about conditions. Examples include Above MS, which is supported by Biogen; Chron’s & Me, sponsored by UCB; Eczema Exposed supported by Sanofi US and Regeneron Pharmaceuticals; GSK’s Asthma.com; HIV information and support site Stop the Virus sponsored by Gilead; and Speak Your Migraine from Amgen and Novartis, among many others.

In addition, companies have begun supporting wellness sites, such as Merck Engage, to encourage consumers to make healthy choices.

With some diseases, particularly rare diseases, social platforms can prove valuable in connecting geographically dispersed patients and providing them with a voice. Social media groups can also be invaluable in providing patients with a forum for sharing concerns and information.

Overcoming Barriers

The industry has faced several constraints with regards to social media. One is certainly the lack of clear guidelines. While the FDA provided draft guidance on the use of social media, those guidelines haven’t been finalized. However, companies must ensure information about risks is made clear. For example, Duchesnay received a warning letter from the FDA after posts by Kim Kardashian promoting its morning sickness pill Diclegis didn’t mention side effects or risks.

Twitter is considered an excellent two-way communication forum, but again lack of guidance leaves companies uncertain as to how to embrace it, at least when it comes to speaking about their products.

In a conversation on this issue with Forbes, cardiologist and blogger Dr. Kevin Campbell warned that pharmaceutical companies would have to tread carefully when hosting any commercially driven discussion and be aware that during recalls or negative press, they could open themselves to legal issues.

The good news, however, is that as of mid-November 2017 the Office of Prescription Drug Promotion (OPDP) had issued only two enforcement letters on marketing communications, showing a marked drop in such activity from the regulators. While these letters aren’t specific to social media, they do indicate a positive trend generally.

Media forums themselves have sometimes created barriers for the industry. For example, in 2011 Facebook announced that all Facebook pages would have to allow comments. This resulted in companies removing many disease-state groups because they lacked the mechanisms and resources to handle comments and remain in compliance. Facebook later rescinded the requirement; however, pharmaceutical companies struggle to find a way to effectively communicate with patients in such forums.

Another barrier has been uncertainty over communicating directly with patients, and in particular, concerns over how those patients will react.

Best Foot Forward

Statistics show that pharma is tapping into social media, albeit more slowly than other industries. Research company eMarketer estimated that in 2016 pharma and healthcare marketers spent $1.64 billion on mobile and online advertising, but projected that would rise to $2.55 billion by 2019.

The social media companies themselves are looking at how to engage pharma companies from a commercial point of view. On June 6, 2017, Facebook hosted a Health Summit for pharmaceutical marketers, and the organization is looking at changes it needs to make to cater to pharmaceutical companies, which increasingly are moving ad budgets from television to digital media.

Google and Twitter have been tapping into the market for a while, hiring teams to focus on pharmaceutical ad campaigns.

Experts in social media advise pharma companies new to social media to take the plunge because patients and caregivers are eager to use these forums to engage. Those new to social platforms might be best advised to start with well-traveled forums such as Facebook and working closely with medical, legal, and regulatory teams to avoid any nasty surprises later. Another sound approach is to start in one disease area and learn as they go.

Companies are also advised to measure the effectiveness of their social media campaigns, especially when it comes to branded campaigns. To avoid falling foul of regulators, some experts recommend companies develop a controlled environment, such as a website for a product, to ensure information is accurate. But if companies provide a patient chat room they may face obligations to correct misinformation.

Social media market intelligence firm Unmetric assessed the metrics, content, and campaigns of 15 brands in terms of social media presence and found most brands put efforts into just a few channels, that fan base is less important than the ability to expand that base, and that reach and impressions don’t correlate with frequency of posting.

Leading the Way

Despite concerns, many pharma companies do recognize the value of social media as a way to reach patients whether in a non-branded way to open the conversation on disease states, or — though less so — from a more commercial perspective.

Some companies have appointed digital leads to advance their social positioning, including: Biogen, which has a head of digital strategy; Sanofi US, which has a head of digital intelligence and connected marketing; Boehringer Ingelheim, with a senior digital manager; and Takeda, with a head of digital acceleration, to name a few.

One of the most successful campaigns was Boehringer Ingelheim’s post during Brain Awareness Week in March 2016, which included a puzzle to highlight cognitive tasks. The post marked the company’s foray into the therapeutic area of CNS, including mental illness.

One strong proponent of social media is Ron Cohen, M.D., CEO of Acorda Therapeutics, who started a digital-innovation-and-strategy group at the company. This has led to several innovations, including a self-help application called MS self that lets users track metrics related to their health. The company is also using digital technology to recruit patients for clinical trials, using multichannel methods to find patients with a condition and inform them of the clinical trials, and providing click throughs so patients can find out more.

Another company looking at social networks for patient recruitment is Bioverativ, which has turned to MyHealthTeams to better understand the unmet needs of hemophilia patients and potentially get them into trials for an upcoming hemophilia drug. Once it gathered input, the company designed its trial to address unmet needs by gauging two key issues raised: continued pain and help with depression.

Companies must take a considered approach to their social media. Sandra Velez, content strategy leader at Merck, says companies must understand their customers’ needs, have two-way conversations with them, and be on channels that customers expect them to be on. She emphasizes the importance of creating a customer persona and understanding that their emotional needs will vary depending on their persona — patient, provider, or payer, for example.(PV)


Via Plus91
more...
nicholas yearwood's curator insight, January 16, 9:20 PM
statistics are very different and new to
Rescooped by Sandra Boyer from GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK
Scoop.it!

e‐health: going back to the source... #hcsm #hcsmeu #hsmeufr #hcsmeues

e‐health: going back to the source... #hcsm #hcsmeu #hsmeufr #hcsmeues | Santé Industrie Pharmaceutique | Scoop.it
e‐health

Via Lionel Reichardt / le Pharmageek
more...
No comment yet.
Rescooped by Sandra Boyer from Le numérique au service de la santé à domicile et de l’autonomie
Scoop.it!

Depuis le 1er janvier 2018, vous pouvez être soigné à distance par votre médecin ! 

Depuis le 1er janvier 2018, vous pouvez être soigné à distance par votre médecin !  | Santé Industrie Pharmaceutique | Scoop.it

La nouvelle loi de la sécurité sociale prévoie un remboursement des actes de téléconsultation.

En d’autres termes, les médecins pourront utiliser les technologies du numérique pour réaliser une consultation et facturer leurs actes comme des actes médicaux classiques.
Mais tous les médecins sont-ils prêts à accepter ces changements ? On peut s’interroger.

Certains craignent d’avoir une charge de travail en plus, d’autres d’être constamment sollicités par leurs patients.

La vieille génération se montre quant à elle peu encline à l’usage des nouvelles technologies, et de manière générale suspicieuse à l’égard de ces patients informés ayant acquis des connaissances médicales hors du champs traditionnel de la consultation.

La «décision partagée», rendue possible par la communication d’informations par le patient grâce au smartphone et à sa connaissance de sa maladie, suscite des inquiétudes et certains mettent en doute la sortie de l’«organisation verticale» de la relation patients-médecins.
Pour autant, ces nouveaux outils technologiques ne prétendent pas remplacer la consultation médicale, ils ne sont que des auxiliaires de santé au service de l’amélioration de la prise en charge du patient.

La télémédecine pourra alors s’insérer dans un parcours de soin. Parmi la population de médecins plus réceptifs à leur usage, ils apparaissent comme un moyen de décharger les urgences, d’alléger au contraire leur emploi du temps et de lutter contre les déserts médicaux.

Permettant un premier diagnostique à distance, les actes de télémédecine permettront pour eux d’éviter les déplacements inutiles dans les centres hospitaliers dont les services sont parfois engorgés ...


Via France Silver Eco
more...
France Silver Eco's curator insight, January 4, 8:48 AM

En matière d’amélioration du parcours de soin numérique, le début de l’année 2018 scelle l’avènement d’une avancée de taille puisque le projet de loi de financement de la sécurité sociale a prévu de faire rentrer la télémédecine dans le droit commun. Les actes de consultation à distance rentrent donc dans le champ médical, la France devient le premier pays industrialisé avec des systèmes publics de télémédecine !

Rescooped by Sandra Boyer from RSE et Développement Durable
Scoop.it!

[#INFOGRAPHIE] Comment le #changement #climatique impacte déjà notre #santé

[#INFOGRAPHIE] Comment le #changement #climatique impacte déjà notre #santé | Santé Industrie Pharmaceutique | Scoop.it
Un virus de la dengue qui se propage à toute vitesse, des millions de malnutris à travers le monde, des épisodes de sécheresse et d’inondations qui s

Via François GARREAU
more...
LaDameduCDI's curator insight, January 8, 6:14 AM
Une infographie claire et démonstrative sur les impacts confirmés du changement climatique
Rescooped by Sandra Boyer from Les actualités du GIE GERS - Groupement pour l'Elaboration et de Réalisation Statistiques
Scoop.it!

La #Blockchain en #Santé : simple promesse ou réalité imminente ? #hcsmeufr #esante

La #Blockchain en #Santé : simple promesse ou réalité imminente ? #hcsmeufr #esante | Santé Industrie Pharmaceutique | Scoop.it
    N°1, Décembre 2017 Article rédigé par Anca PETRE (Etudiante en double cursus de Pharmacie et de Management ; Chief Operating Officer chez 23 Consulting, un des partenaires officiels de www.managersante.com   La blockchain est la technologie à la mode de ces dernières années. Les articles qui décrivent son utilisation et son fonctionnement ne manques pas. Elle apparait…

Via GIE_GERS
more...
GIE_GERS's curator insight, December 18, 2017 3:41 AM
La Blockchain en Santé : simple promesse ou réalité imminente ?